Parameter
| Biomarker | VEGF | Full name | Vascular endothelial growth factor | Molecular Type | Protein（Cytokines / Angiogenic factors） |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis、Prediction of treatment response |
| Disease | Renal Cell Carcinoma(RCC) | Disease Subtypes | / | ||
| Organ | Kidney | Test Sample / Technology Platform | Serum（ELISA） | ||
| Pathobiological Mechanisms | Regulating RCC angiogenesis is the core target of VEGF-targeted therapy | ||||
| Clinical Availability Status | Clinical validation/Routine application: Included in multiple clinical trial prognostic assessments; partially utilized for monitoring the efficacy of targeted therapy | ||||
| Notes and Dynamics | Patients with high baseline VEGF levels may benefit more from sorafenib therapy; associated with tumor invasion and metastasis | ||||